NCT05205447View on ClinicalTrials.gov

Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants

PHASE1TerminatedINTERVENTIONAL

Enrollment

27

Participants

Timeline

Start Date

January 5, 2022

Primary Completion Date

April 12, 2022

Study Completion Date

April 12, 2022

Conditions

Healthy

Interventions

DRUG

LY3410738

Oral LY3410738

DRUG

Itraconazole

Oral Itraconazole

DRUG

Carbamazepine

Oral Carbamazepine

Trial Locations (1)

32117

LabCorp CRU, Inc., Daytona Beach

Sponsors

Collaborators (1)

Loxo Oncology, Inc.

All Listed Sponsors

collaborator

Loxo Oncology, Inc.

INDUSTRY

lead

Eli Lilly and Company

INDUSTRY

NCT05205447 - Study of the Effects of Itraconazole and Carbamazepine on LY3410738 in Healthy Participants | Biotech Hunter | Biotech Hunter